1.
Choucair* N, Saker* Z, Kheir Eddine* H, Bahmad* HF, Fares Y, Zaarour M, Harati H, Nabha S. Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma. Pathologica [Internet]. 2022Apr.28 [cited 2024Nov.7];114(2):128-37. Available from: https://old.pathologica.it/article/view/294